Quantcast

Latest Clinical trial Stories

2014-05-09 08:25:35

DUBLIN, May 9, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/lhq655/project) has announced the addition of the "Project Management for Pharma Professionals - The Leading Project Management Course for the Bio / Pharma Industry (London)" conference to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The Project Management for Pharma Professionals course will take place on the 16-17 June 2014 at The Rembrandt Hotel, London THIS...

2014-05-08 16:27:40

REDWOOD CITY, Calif., May 8, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three months ended March 31, 2014. "In the first quarter of the year, we have focused on preparation for commercialization of Zalviso both in the U.S. and Europe. This includes working with the FDA on...

2014-05-08 16:26:54

-- Provides Update on Clinical Programs and Timelines -- SOUTH SAN FRANCISCO, Calif., May 8, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced financial results for the first quarter of 2014 and provided an update on its current clinical programs and timelines. http://photos.prnewswire.com/prnvar/20130225/MM66380LOGO Development Program Updates KB001-A Enrollment in the Phase 2 study in cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa (Pa)...

2014-05-07 12:30:15

Standardizing Site Networks for CNS Clinical Trials Boosts Signal Detection HAMILTON, N.J., May 7, 2014 /PRNewswire/ -- MedAvante, Inc., the world's leading provider of centralized assessments and quality control in clinical trials of treatments for central nervous system (CNS) disorders, announced the Virgil Investigative Study Platform for use by drug developers and their global cohort of trial sites. For the first time, the Virgil platform puts tools built with MedAvante science...

2014-05-07 10:04:54

Researchers at Fred Hutchinson Cancer Research Center demonstrate high-value investment of public funds has substantial economic return Economic findings were released today on the Women’s Health Initiative (WHI), estrogen plus progestin (E+P) trial. The WHI is one of the largest National Institutes of Health-funded studies ever conducted on women. Housed at the Fred Hutchinson Cancer Research Center in Seattle, it is a 15-year, multimillion-dollar study established in 1991, involving...

2014-05-07 08:33:54

BOSTON, May 7, 2014 /PRNewswire/ -- AG Mednet and the board-certified, fellowship-trained radiologists at Imaging Endpoints believe strongly that every clinical trial data point counts, from pre-clinical through FDA submission. To support its guarantee of accuracy, compliance, real-time reads and sponsor confidence, Imaging Endpoints is utilizing AG Mednet's Submission Quality and Compliance software for oncology, neurology, musculoskeletal and cardiovascular clinical trials....

2014-05-07 08:32:51

LA JOLLA, Calif., May 7, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced the expansion of its Board of Directors with the appointment of two new members: -- Lynn D. Bleil, former leader of McKinsey & Company's West Coast Healthcare Practice and a leader of the worldwide Healthcare Practice --...

2014-05-07 08:32:37

Software runs on tablets and smartphones to enable video visits and collection of digital health and patient-reported data in clinical trials NEW YORK, May 7, 2014 /PRNewswire/ -- AMC Health, a leading provider of telehealth solutions, today announced the release of a software platform designed to remotely collect clinical trial data. The mobile solution that runs on Android tablets and smartphones supports video visits and the collection of digital health and self-reported data to...

2014-05-07 08:32:14

First-in-class DOT1L Inhibitor in Clinical Development as Potential Personalized Therapeutic for Patients with Genetically Defined Acute Leukemias CAMBRIDGE, Mass., May 7, 2014 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced the initiation of a Phase 1b open-label clinical study of EPZ-5676 in pediatric patients with acute leukemias...

2014-05-06 08:36:03

CLEVELAND, May 6, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics today announced that top-line interim data from its ongoing Phase II STOP-HF study will be presented in a late-breaking oral presentation at the European Society of Cardiology Heart Failure Congress (ESC-HF) taking place May 17 - 20, 2014 in Athens, Greece. The STOP-HF trial is a randomized, placebo-controlled, double-blinded study conducted at 15 centers in the United States to evaluate safety and efficacy of...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.